Executive management

BSc in Mechanical Engineering from ETH Zürich and a MEng in Product Development from the KTH Royal Institute of Technology in Stockholm, a MScEng in Industrial engineering and Production, Supply Chain Management and Integrated Product Development and a PhD in Innovation and Technology Management from ETH Zürich.

Owner of Innoverse GmbH.

CEO of Indical Bioscience, various positions at Novozymes and Consultant at Bain & Company.

1,907,812 ordinary shares, 1,214,554 C shares.
Subscribed for a total of 250,836 warrants in the Company under LTI 2021.

Master of Science in Electrical Engineering from the Royal Institute of Technology and Master of Science in Business Administration from Stockholm University.

Owner of Calan Consulting AB.

CEO at Careium AB, CEO and CFO at DORO AB, CFO at Lekolar, Vice President Business Development at Beijer Electronics, and consultant at Capgemini Invent.

0 ordinary shares, 0 C shares.
0 warrants.

MSc in Business and Economics from the Stockholm School of Economics.

Chairman of the board of a number of subsidiaries within the Group. Board member of a number of subsidiaries within the Group and Nextmune BV, Nextmune US LLC, Nextmune AS, Nextmune Spain S.L., Diavet S.L., I.C.F. S.r.l., DRN S.r.l., and Vetruus Limited.

VP Corporate Strategy and M&A at Meda.

2,143,061 ordinary shares, 1,367,912 C shares.
Subscribed for a total of 125,418 warrants in the Company under LTI 2021.

MSc in Bioengineering from The University of Pennsylvania and MBA from The Pennsylvania State University.

President & General Manager Lima Corporate in the US, managerial positions in sales, marketing, product development and innovation at Synthes and Johnson & Johnson’s MedTech division.

0 ordinary shares, 0 C shares.
0 warrants.

MSc in Management, Technology and Economics from ETH Zürich.

Chairman of the board of KYON AG. Board member of Kyon Pharma (US) and Ossium AG.

CEO of Kyon, General Manager of Joint Replacement Division at Stryker and Sales Manager at Johnson & Johnson.

663,889 ordinary shares, 344,318 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021.

MSc in Economics and Business Administration from the Stockholm School of Economics.

Chairman of the board and board member of a number of subsidiaries within the Group. Board member of Famano AB.

Group CEO of Omnicom Media Group Sweden, COO MTGx and Head of Digital MTG

Chairman of the Board OMD Sweden, Chairman of the Board PHD Sweden, Chairman of the Board Hearts & Science Sweden, Chairman of the Board Drum Sweden. Member of Board Splay Networks & Member of Board Godsmak.se.

292 064 ordinary shares, 125 170 C shares.
0 warrants

Bachelor of Economics (Honours) at LUISS Guido Carli University in Rome.

Director at Ontario Teachers’ Pension Plan, Principal at Bain & Company and Consultant at Ernst & Young.

0 ordinary shares, 0 C shares.
0 warrants.

MSc in Finance from the Stockholm School of Economics.

Board member of HRR Holding AB and Danzinger Gatt Invest AB.

Head of M&A at Doktor.se, Group M&A Manager at AniCura and Investment Manager at Nordic Capital.

174,250 ordinary shares, 104,550 C shares.
0 warrants.

MSc in Accounting and Financial Management from the Stockholm School of Economics.

Group Communications Director at AniCura, Head of Marketing & Communications at Moderna Försäkringar and Consultant at JKL Group.

7,300 ordinary shares, 0 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021.

Master of laws - LLM from Lund University
Bachelor of Business Administration – Finance from Lund University

Board member of Elding Oscarson Arkitekter AB
Board member of Tapster AB

Vice President and Chief Counsel International Operations at Zoetis
Assistant General Counsel at Pfizer
Attorney (Advokat) at Mannheimer Swartling Law Firm

17 000 ordinary shares
0 warrants